IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 18 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,057,674 | -8.3% | 34,375,000 | -7.1% | 0.73% | -6.3% |
| Q2 2023 | $37,148,608 | +67.6% | 37,010,000 | +68.2% | 0.78% | +76.6% |
| Q1 2023 | $22,162,113 | +70.5% | 22,000,000 | +83.3% | 0.44% | +41.9% |
| Q4 2022 | $12,996,787 | +4.5% | 12,000,000 | -2.7% | 0.31% | +8.8% |
| Q3 2022 | $12,434,000 | -18.3% | 12,334,000 | -14.4% | 0.28% | -16.9% |
| Q2 2022 | $15,218,000 | +29.4% | 14,416,000 | +38.4% | 0.34% | +49.8% |
| Q1 2022 | $11,756,000 | +1.7% | 10,416,000 | 0.0% | 0.23% | -5.4% |
| Q4 2021 | $11,561,000 | -6.1% | 10,416,000 | 0.0% | 0.24% | -14.5% |
| Q3 2021 | $12,314,000 | +0.8% | 10,416,000 | 0.0% | 0.28% | +6.8% |
| Q2 2021 | $12,212,000 | +5.8% | 10,416,000 | 0.0% | 0.26% | -10.8% |
| Q1 2021 | $11,544,000 | -1.2% | 10,416,000 | 0.0% | 0.30% | -9.7% |
| Q4 2020 | $11,690,000 | +12.2% | 10,416,000 | -0.8% | 0.33% | -17.3% |
| Q3 2020 | $10,422,000 | – | 10,500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 12,388 | $12,458,000 | 0.88% |
| SHENKMAN CAPITAL MANAGEMENT INC | 13,818,000 | $13,900,000 | 0.78% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,510,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,655,000 | $28,803,000 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,334,000 | $12,434,000 | 0.28% |
| CSS LLC/IL | 5,000,000 | $5,024,000 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,700,000 | $22,913,000 | 0.14% |
| Jefferies Group LLC | 7,347,000 | $7,413,724 | 0.06% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 26,000 | $26,000 | 0.04% |
| Calamos Advisors LLC | 7,500,000 | $7,542,000 | 0.03% |